Implication for health policy/practice/research/medical education:Deferoxamine is used to treat chronic iron overload in patients with β-thalassemia. Short half-time of deferoxamine and the need of repetitive injections can lead to side effects. Patients should be monitored periodically for complications. Keeping deferoxamine therapeutic index can avoid drug overdose and side effects.
Please cite this paper as: Keikhaei B, Farmani-Anooshe N, Bahadoram M, Mahmoudian-Sani MR, Alikhani K, Helalinasab A. An overview of complications associated with deferoxamine therapy in thalassemia. J Nephropharmacol. 2021;10(1):e05. DOI: 10.34172/npj.2021.05.